Towards a new horizon in prostate cancer: PSMA-targeted Docetaxel-conjugated nanomedicines for intratumoral treatment in xenograft model

Towards a new horizon in prostate cancer: PSMA-targeted Docetaxel-conjugated nanomedicines for intratumoral treatment in xenograft model

Saved in:
Bibliographic Details
Published in:European urology Vol. 83; p. S1672
Main Authors: Bernal Gomez, A., Rivero-Buceta, E., Vidaurre-Agut, C., Vera-Donoso, C.D., Moreno-Manzano, V., Lopez-Moncholi, E., Benlloch, J.M., Botella, P.
Format: Journal Article
Language:English
Published: 01-02-2023
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:0302-2838
DOI:10.1016/S0302-2838(23)01196-X